AGALSIDASE BETA (Fabrazyme) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

AGALSIDASE BETA

What is the Trade Name for AGALSIDASE BETA

Fabrazyme

What is the Indication for AGALSIDASE BETA

  • 1 INDICATIONS AND USAGE Fabrazyme ¬Æ is indicated for the treatment of adult and pediatric patients 2 years of age and older with confirmed Fabry disease. Fabrazyme is a hydrolytic lysosomal neutral glycosphingolipid-specific enzyme indicated for the treatment of adult and pediatric patients 2 years of age and older with confirmed Fabry disease. ( 1 )

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]